Evidence map›Paper›PMID 41712065›Full record

ReviewDiscover nano2026

Bridging cancer therapies: the role of magnetic nanoparticles in combination cancer therapy.

Sajedeh Ebrahim Damavandi, Sayed Mustafa Banihashemi Jozdani, Zahra Elyasigorji, Massoud Vosough

Abstract readReview
In one paragraph

Review in Discover nano, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Sajedeh Ebrahim Damavandi *Laboratory of Membrane Biophysics and Macromolecules, Institute of Biochemistry and Biophysics, University of Tehran, Tehran, Iran. e.damavandi@ut.ac.ir.
Sayed Mustafa Banihashemi Jozdani *Department of Regenerative Medicine, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran.
Zahra Elyasigorji *Department of Cell and Molecular Biology, Faculty of Life Sciences and Biotechnology, Shahid Beheshti University, Tehran, Iran.
Massoud VosoughDepartment of Regenerative Medicine, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran. masvos@royaninstitute.org.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite the efforts of the medical and research community for effective treatments, cancer is one of the leading causes of death worldwide. Cancer cells' enduring resistance is a significant cause of treatment failure. One of the most effective approaches proposed to overcome this resistance is a combination therapy. This is a transformative strategy by integrating complementary techniques such as radiation therapy, immunotherapy, photothermal treatment, photodynamic therapy, and hyperthermia, as well as combined with chemotherapy. Numerous studies have investigated the synergistic effects of these therapies to identify the most effective methods for cancer therapy. Researchers also found that magnetic nanoparticles can play a central and innovative role by enhancing the synergistic interactions of combination therapies. Their magnetic reactivity, high surface-to-volume ratio, and surface functionalization enable precise tumor-selective targeting, controlled drug delivery, and efficient conversion of light into heat. They can act as mediators, providing significant benefits when two or more therapeutic methods are used simultaneously. This can enhance their effectiveness. Mechanistically, magnetic nanoparticle-mediated hyperthermia enhances chemotherapy efficacy by elevating tumor temperatures, increasing membrane permeability, and promoting tumor sensitization to radiotherapy. The production of reactive oxygen species (ROS) in cancerous cells, the exacerbation of oxidative damage during photothermal therapy, and the enhancement of immune activation in combined immunotherapeutic approaches improve the effectiveness of chemotherapy. Biocompatible materials such as PEG, chitosan, and dextran can further stabilize these nanoparticles, and ligand functionalization enhances selective tracking of cancer cells. This article provides a comprehensive review of the multifunctional role of magnetic nanoparticles across diverse therapeutic combinations, including radiotherapy, immunotherapy, photothermal therapy, photodynamic therapy, and hyperthermia. It will help those interested in this research topic to comprehensively and validly compare and investigate various studies, make informed decisions, and introduce next-generation Magnetic nanoparticle-based combination therapies for cancer treatment.

Indexed as

Combination cancer treatmentHyperthermia therapyMagnetic NPsPhotodynamic therapyPhotothermal therapyRadiotherapy

Identifiers

PMID41712065
PMCPMC12920867

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.